• Z-LEHD-FMK in Translational Apoptosis: Precision Tools for C

  2026-07-31

  Explore how Z-LEHD-FMK, a selective irreversible caspase-9 inhibitor, advances apoptosis research beyond standard assays—revealing new strategies for cell death detection, neuroprotection, and cardioprotection. This article uniquely bridges mechanism, protocol, and translational insight.

• MK-5108 (VX-689): Translational Aurora A Inhibition Beyond R

  2026-07-31

  Explore how MK-5108 (VX-689) redefines selective Aurora A kinase inhibition, with unique insight into its mechanism, assay protocol optimization, and practical implications for tumor cell proliferation studies. Discover an advanced, evidence-driven resource for cancer research.

• MK-5108 (VX-689): Precision Aurora A Inhibition in High-Risk

  2026-07-30

  Explore how MK-5108 (VX-689), a highly selective Aurora A kinase inhibitor, advances cancer research by enabling precise cell cycle arrest and tumor suppression assays. This in-depth analysis reveals unique insights from recent retinoblastoma studies and practical guidance for advanced oncology workflows.

• 2-Hydroxypropyl-β-cyclodextrin: Solubility Workflows & QC Gu

  2026-07-30

  2-Hydroxypropyl-β-cyclodextrin addresses the challenge of solubilizing poorly water-soluble, hydrophobic compounds—especially those with aromatic or phenyl groups—by forming aqueous inclusion complexes. Its validated use is in pharmaceutical and biochemical research as a drug formulation excipient or solubility enhancer. Applications outside these contexts lack documented support and are not recommended.

• GluN2A/B Regulation of Gap Junctions in TMJ Inflammatory All

  2026-07-29

  This study demonstrates that NMDA receptor subunits GluN2A and GluN2B mediate the expression of connexins and pannexins in trigeminal ganglia, contributing to orofacial pain during TMJ inflammation. By detailing distinct signaling pathways and glial cell interactions, the work identifies novel targets for therapeutic intervention in inflammatory allodynia.

• Tropifexor (LJN452): Precision FXR Modulation in Barrier Res

  2026-07-29

  Tropifexor (LJN452) empowers researchers to dissect FXR-driven metabolic and intestinal barrier pathways with sub-nanomolar potency. This guide translates recent advances in triacetin metabolism and epithelial defense into actionable experimental workflows, troubleshooting, and comparative insights.

• RNAi Screening Uncovers Vesicular Transport in SARS-CoV-2 Re

  2026-07-28

  Kerr et al. present an arrayed RNA interference screen that systematically identifies host vesicular transport factors crucial for SARS-CoV-2 release, particularly implicating Rab11a-mediated cargo delivery. Their findings clarify previously underexplored viral egress mechanisms and highlight CDK9 inhibition as a potential strategy for host-targeted antivirals.

• Ibuprofen Toxicology and Biodegradation: Environmental Persp

  2026-07-28

  Janet Jan-Roblero and Juan A. Cruz-Maya's 2023 review critically examines the toxicological impact and environmental persistence of ibuprofen as an emerging contaminant. The paper highlights the gap between high global consumption and limited biodegradation strategies, underlining the need for improved removal technologies and further research on bacterial degradation.

• SMYD2 Inhibition Mitigates Renal Fibrosis in Cisplatin-Induc

  2026-07-27

  This study demonstrates that pharmacological inhibition of SMYD2, particularly with AZ505, reduces renal fibrosis and inflammation in cisplatin-induced chronic kidney disease (CKD) models. The findings highlight SMYD2 as a promising epigenetic target in renal pathology, providing new mechanistic insights and supporting the use of selective SMYD2 inhibitors in translational fibrosis research.

• Tamsulosin (C6445): Mechanistic Insights for Precision POUR

  2026-07-27

  Explore how Tamsulosin, a selective α₁A-adrenergic receptor antagonist, redefines precision prophylaxis for postoperative urinary retention (POUR) and ureteral stone expulsion. This article provides a mechanistic and translational perspective, integrating meta-analytic evidence with advanced protocol guidance for research and clinical assay design.

• Bleomycin Sulfate: Technical Guide for DNA Damage and Fibros

  2026-07-26

  Bleomycin Sulfate (Blenoxane) provides a reliable reagent for modeling DNA strand breaks, chemotherapy-induced cell injury, and pulmonary fibrosis in both cell lines and animal studies. It excels where precise, reproducible induction of DNA damage or fibrosis is needed, but requires careful handling and protocol adherence for optimal results. Use is not recommended in workflows needing ethanol solubility or long-term solution storage.

• V5 Epitope Tag Peptide: Precision in Protein Detection Workf

  2026-07-25

  The V5 Epitope Tag Peptide (GKPIPNPLLGLDST) unlocks high-specificity detection and multiplexing possibilities for recombinant protein workflows. Advanced single-molecule screening and robust solubility ensure reliable results in Western blotting, immunoprecipitation, and super-resolution imaging. Discover how this tag, supplied by APExBIO, streamlines both standard and next-generation molecular assays.

• Multiplexed Analysis of Avian Auditory Hair Cell Regeneratio

  2026-07-24

  Sato et al. present a detailed protocol for inducing and analyzing auditory hair cell loss and regeneration in the avian inner ear, integrating ototoxin ablation, multiplexed mRNA detection, immunohistochemistry, and S-phase labeling. The approach advances mechanistic studies of sensory regeneration and enables high-resolution mapping of gene and protein dynamics during repair.

• Rifampin Workflows: Precision Transcription Inhibition for R

  2026-07-24

  Rifampin, a rifamycin antibiotic, is the benchmark tool for precise transcription inhibition in bacterial resistance and synthetic biology research. This guide unpacks experimental workflows, troubleshooting strategies, and novel applications—anchored by the latest advances in light-inducible gene regulation.

• (+)-Bicuculline: Protocols, Workflow, and Practical Use in R

  2026-07-23

  (+)-Bicuculline is a classical GABAA receptor antagonist used in neuroscience research to dissect inhibitory neurotransmission and analyze synaptic NMDA receptor signaling modulation. Its proper application is limited to controlled laboratory studies, and it is not suitable for diagnostic, clinical, or therapeutic use.

8384 records 5/559 page Previous Next 12345 下5页 Last page